Dysregulation of miRNAs Targeting the IGF-1R Pathway in Pancreatic Ductal Adenocarcinoma
Background: Pancreatic ductal adenocarcinoma (PDAC), the most prevalent neoplastic lethal pancreatic disease, has a poor prognosis and an increasing incidence. The insulin-like growth factor-1 receptor (IGF-1R) signaling pathway is considered to be a contributing factor to the progression, metastasi...
Main Authors: | Maria Dobre, Vlad Herlea, Cătălina Vlăduţ, Mihai Ciocîrlan, Vasile Daniel Balaban, Gabriel Constantinescu, Mircea Diculescu, Elena Milanesi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/10/8/1856 |
Similar Items
-
Pancreatic ductal adenocarcinoma in colonic wall: metastatic disease or cancerized pancreatic ectopic tissue?
by: Graziana Gallo, et al.
Published: (2020-04-01) -
Role of NF-Kappa B for the Approach of Pancreatic Ductal Adenocarcinoma
by: Deniz Tuncel
Published: (2015-12-01) -
Differentiation of chronic mass-forming pancreatitis from pancreatic ductal adenocarcinoma using contrast-enhanced computed tomography
by: Ren S, et al.
Published: (2019-08-01) -
AAV-mediated pancreatic overexpression of Igf1 counteracts progression to autoimmune diabetes in mice
by: Cristina Mallol, et al.
Published: (2017-07-01) -
Dynamic perfusion CT – A promising tool to diagnose pancreatic ductal adenocarcinoma
by: Zaborienė Inga, et al.
Published: (2021-02-01)